Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Co-Diagnostics Inc (CODX)

Co-Diagnostics Inc (CODX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 520,859
  • Shares Outstanding, K 27,457
  • Annual Sales, $ 210 K
  • Annual Income, $ -6,200 K
  • 60-Month Beta -2.56
  • Price/Sales 2,291.06
  • Price/Cash Flow N/A
  • Price/Book 25.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.61
  • Number of Estimates 1
  • High Estimate 0.61
  • Low Estimate 0.61
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +862.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.01 +26.38%
on 06/11/20
20.56 -7.73%
on 07/02/20
+2.97 (+18.56%)
since 06/08/20
3-Month
8.53 +122.46%
on 04/09/20
29.72 -36.17%
on 05/14/20
+10.27 (+118.05%)
since 04/08/20
52-Week
0.81 +2,241.98%
on 07/09/19
29.72 -36.17%
on 05/14/20
+18.13 (+2,158.33%)
since 07/08/19

Most Recent Stories

More News
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Co-Diagnostics, ProAssurance, Enphase, and Chembio and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Co-Diagnostics, Inc. (NASDAQ: CODX),...

CODX : 18.97 (+5.74%)
PRA : 13.64 (+1.11%)
ENPH : 54.93 (+8.47%)
CEMI : 4.27 (+12.07%)
Customer Interest in Wearable Devices Grows as Innovative Applications are Added

, /PRNewswire/ -- The wearable device market is largely driven by the increasing awareness of the importance of leading a healthy lifestyle and fitness. In addition, recent technological advancements...

INOTF : 0.0350 (-0.57%)
NMRD : 8.02 (+2.56%)
CODX : 18.97 (+5.74%)
IBIO : 2.31 (+2.67%)
FLIR : 39.78 (-1.36%)
JNJ : 143.27 (+0.29%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Co-Diagnostics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2020 - CODX

New York, New York--(Newsfile Corp. - July 7, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:

CODX : 18.97 (+5.74%)
LAWSUITS FILED AGAINST WFC, CEMI and CODX - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

NEW YORK, NY / ACCESSWIRE / July 7, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased...

WFC : 24.55 (+0.37%)
CEMI : 4.27 (+12.07%)
CODX : 18.97 (+5.74%)
Co-Diagnostics Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Co-Diagnostics, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - July 7, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Co-Diagnostics, Inc. ("Co-Diagnostics" or the "Company") (NASDAQ:...

CODX : 18.97 (+5.74%)
SHAREHOLDER ALERT: ENDP CODX BKD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / July 6, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss...

ENDP : 3.41 (-5.80%)
CODX : 18.97 (+5.74%)
BKD : 2.64 (-3.30%)
SHAREHOLDER ALERT: ENDP CODX IDEX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / July 6, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss...

IEX : 157.81 (-0.33%)
ENDP : 3.41 (-5.80%)
CODX : 18.97 (+5.74%)
IDEX : 1.5600 (+23.81%)
CLASS ACTION UPDATE for ENDP, CODX and IDEX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / July 6, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested...

ENDP : 3.41 (-5.80%)
CODX : 18.97 (+5.74%)
IDEX : 1.5600 (+23.81%)
Pomerantz Law Firm Announces the Filing of a Class Action against Co-Diagnostics, Inc. and Certain Officers - CODX

Pomerantz LLP announces that a class action lawsuit has been filed against Co-Diagnostics, Inc. ("Co-Diagnostics" or the "Company")(NASDAQ: CODX) and certain of its officers. The class action, filed in...

CODX : 18.97 (+5.74%)
ABT : 92.58 (+0.13%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Co-Diagnostics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2020 - CODX

New York, New York--(Newsfile Corp. - July 6, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:

CODX : 18.97 (+5.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CODX with:

Business Summary

Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology...

See More

Key Turning Points

2nd Resistance Point 19.98
1st Resistance Point 19.48
Last Price 18.97
1st Support Level 18.19
2nd Support Level 17.40

See More

52-Week High 29.72
Last Price 18.97
Fibonacci 61.8% 18.68
Fibonacci 50% 15.26
Fibonacci 38.2% 11.85
52-Week Low 0.81

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar